secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2024-07-18T23:59:59+00:00
Accession:  0000950170-24-084629
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio enters $5.85M promissory notes at 12% from major shareholders, repays MidCap debt, expands board
--------------------------------------------------------------------------------

- Issued $5.85M promissory notes to Novalis and Northpond at 12% annual interest, maturing Jan 16, 2026.
- Repaid $5.84M to MidCap Financial, terminating existing term and revolver loan agreements.
- Board expanded from 8 to 13; five new directors appointed: Hlavinka, Golub, Hodges, Weissman, Krueger.
- Side letter gives lenders board control: majority of nominating committee, replacement rights while >10% ownership.
- Registration rights waiver defers liquidated damages and waives accrued interest for a set period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/tbio-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-084629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer